71
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

QUANTITATIVE ANALYSIS OF TEN DITERPENOIDS IN RAT BILE AFTER ORAL ADMINISTRATION OF Isodon rubescens EXTRACT BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY-ELECTROSPRAY IONIZATION TANDEM MASS SPECTROMETRY

, , , , , & show all
Pages 1264-1279 | Published online: 04 Apr 2013
 

Abstract

Diterpenoids are the primary bioactive ingredients in Isodon rubescens named Dong Ling Cao in China which possess many pharmacological activities, including anti-tumor, anti-microbial, anti-inflammatory, anti-catastrophe, anti-oxidation, and anti-inflammatory effects. We employed a sensitive and selective high-performance liquid chromatography–electrospray ionization–tandem mass spectrometry (HPLC–ESI–MS/MS) method for the quantification of ten diterpenoids in rat bile. The ten diterpenoids are effusanin A (1), lasiodonin (2), oridonin (3), epinodosin (4), nodosin (5), ponicidin (6), rabdoternin A (7), enmenol (8), lasiokaurin (9), and lasiokaurinol (10). The sulfamethoxazole was used as internal standard (IS). The bile samples were pretreated by liquid-liquid extraction with ethyl acetate (EtOAc). Chromatographic separation was performed on a C18 column with linear gradient elution using water and methanol at a flow rate of 0.8 mL/min. The precursor and product ions of analytes were monitored on a hybrid quadrupole linear ion trap mass spectrometer equipped with a turbo ion spray interface in positive and negative mode, respectively, using multiple–reaction monitoring (MRM). The specificity, linearity, accuracy, precision, recovery, matrix effect, and several of stabilities have been validated for diterpenoids in rat bile samples. The results showed that this method is robust, specific, and sensitive and it can successfully fulfill the requirement of excretion study of the ten diterpenoids in Isodon rubescens.

ACKNOWLEDGMENT

This work received financial support from the Natural Science Foundation of Hebei Province- CSPC Pharmaceutical Joint Research Fund, China (C2011206174).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.